Protein Variants | Comment | Organism |
---|---|---|
A408F | virtual point mutation, modelling | Escherichia coli |
D304A | virtual point mutation, modelling | Escherichia coli |
D304C | virtual point mutation, modelling | Escherichia coli |
D304I | virtual point mutation, modelling | Escherichia coli |
D304M | virtual point mutation, modelling | Escherichia coli |
D304P | virtual point mutation, modelling | Escherichia coli |
D304S | virtual point mutation, modelling | Escherichia coli |
D304T | virtual point mutation, modelling | Escherichia coli |
D304V | virtual point mutation, modelling | Escherichia coli |
I164D | virtual point mutation, modelling | Escherichia coli |
I164E | virtual point mutation, modelling | Escherichia coli |
I164L | virtual point mutation, modelling | Escherichia coli |
I164P | virtual point mutation, modelling | Escherichia coli |
I164Q | virtual point mutation, modelling | Escherichia coli |
I164R | virtual point mutation, modelling | Escherichia coli |
K168F | virtual point mutation, modelling | Escherichia coli |
K168I | virtual point mutation, modelling | Escherichia coli |
K168L | virtual point mutation, modelling | Escherichia coli |
K87F | virtual point mutation, modelling | Escherichia coli |
K87W | virtual point mutation, modelling | Escherichia coli |
K87Y | virtual point mutation, modelling | Escherichia coli |
L60F | virtual point mutation, modelling | Escherichia coli |
L60W | virtual point mutation, modelling | Escherichia coli |
additional information | point mutation is performed virtually in the active site of the Escherichia coli GAD in order to increase thermal stability and catalytic activity of the enzyme, overview. Molecular modelling results indicate that performing mutation separately at positions 164, 302, 304, 393, 396, 398 and 410 increase binding affinity to substrate. The enzyme is predicted to be more thermostable in all 7 mutants based on DDG value. Stabilizing mutations in the active site based on DDG value, and binding energy levels, overview. Cavity volume change analysis for selected mutants | Escherichia coli |
N302A | virtual point mutation, modelling | Escherichia coli |
N302C | virtual point mutation, modelling | Escherichia coli |
N302F | virtual point mutation, modelling | Escherichia coli |
N302I | virtual point mutation, modelling | Escherichia coli |
N302L | virtual point mutation, modelling | Escherichia coli |
N302M | virtual point mutation, modelling | Escherichia coli |
N302P | virtual point mutation, modelling | Escherichia coli |
N302S | virtual point mutation, modelling | Escherichia coli |
N302T | virtual point mutation, modelling | Escherichia coli |
N302V | virtual point mutation, modelling | Escherichia coli |
N316F | virtual point mutation, modelling | Escherichia coli |
N316W | virtual point mutation, modelling | Escherichia coli |
N316Y | virtual point mutation, modelling | Escherichia coli |
N83P | virtual point mutation, modelling | Escherichia coli |
N83W | virtual point mutation, modelling | Escherichia coli |
Q309C | virtual point mutation, modelling | Escherichia coli |
Q309I | virtual point mutation, modelling | Escherichia coli |
Q309K | virtual point mutation, modelling | Escherichia coli |
Q309R | virtual point mutation, modelling | Escherichia coli |
Q309S | virtual point mutation, modelling | Escherichia coli |
Q309T | virtual point mutation, modelling | Escherichia coli |
Q309V | virtual point mutation, modelling | Escherichia coli |
R319F | virtual point mutation, modelling | Escherichia coli |
R319I | virtual point mutation, modelling | Escherichia coli |
R319L | virtual point mutation, modelling | Escherichia coli |
R319M | virtual point mutation, modelling | Escherichia coli |
R319W | virtual point mutation, modelling | Escherichia coli |
R319Y | virtual point mutation, modelling | Escherichia coli |
R398F | virtual point mutation, modelling | Escherichia coli |
R398I | virtual point mutation, modelling | Escherichia coli |
R398L | virtual point mutation, modelling | Escherichia coli |
R398M | virtual point mutation, modelling | Escherichia coli |
R398W | virtual point mutation, modelling | Escherichia coli |
R398Y | virtual point mutation, modelling | Escherichia coli |
S246C | virtual point mutation, modelling | Escherichia coli |
S246F | virtual point mutation, modelling | Escherichia coli |
S246I | virtual point mutation, modelling | Escherichia coli |
S246L | virtual point mutation, modelling | Escherichia coli |
S246M | virtual point mutation, modelling | Escherichia coli |
S246V | virtual point mutation, modelling | Escherichia coli |
S246W | virtual point mutation, modelling | Escherichia coli |
S246Y | virtual point mutation, modelling | Escherichia coli |
S396C | virtual point mutation, modelling | Escherichia coli |
S396F | virtual point mutation, modelling | Escherichia coli |
S396I | virtual point mutation, modelling | Escherichia coli |
S396L | virtual point mutation, modelling | Escherichia coli |
S396M | virtual point mutation, modelling | Escherichia coli |
S396R | virtual point mutation, modelling | Escherichia coli |
S396V | virtual point mutation, modelling | Escherichia coli |
S396W | virtual point mutation, modelling | Escherichia coli |
S396Y | virtual point mutation, modelling | Escherichia coli |
T214F | virtual point mutation, modelling | Escherichia coli |
T214L | virtual point mutation, modelling | Escherichia coli |
T410P | virtual point mutation, modelling | Escherichia coli |
T410V | virtual point mutation, modelling | Escherichia coli |
Y393E | virtual point mutation, modelling | Escherichia coli |
Y393K | virtual point mutation, modelling | Escherichia coli |
Y393Q | virtual point mutation, modelling | Escherichia coli |
Y393R | virtual point mutation, modelling | Escherichia coli |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | the C-terminal domain by entrancing into the active site is responsible for autoinhibition of the enzyme at neutral pH | Escherichia coli |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | - |
Escherichia coli | 5737 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-glutamate | Escherichia coli | - |
4-aminobutanoate + CO2 | - |
ir |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Escherichia coli | P69908 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-glutamate | - |
Escherichia coli | 4-aminobutanoate + CO2 | - |
ir |
Subunits | Comment | Organism |
---|---|---|
homohexamer | a trimer of dimers | Escherichia coli |
More | Escherichia coli GAD forms a hexamer at acidic pH which consists of three functional dimers. In each dimer there are some special residues from both subunits that contribute in the formation of potential active sites and promote the interaction between the enzyme, cofactor and substrate. The N- and C-terminal domains of each subunit play an important role in conformational changes through pH shift. These conformational changes lead to activation of the enzyme at acidic pH and vice versa. The N-terminal residues involve in dimerization and subsequent migration of GAD to cytoplasmic site of the inner. The C-terminal domain by entrancing into the active site is also responsible for autoinhibition of the enzyme at neutral pH | Escherichia coli |
Synonyms | Comment | Organism |
---|---|---|
GAD | - |
Escherichia coli |
GadA | - |
Escherichia coli |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
pyridoxal 5'-phosphate | - |
Escherichia coli |
General Information | Comment | Organism |
---|---|---|
additional information | molecular modelling of the active site, docking study, using the crystal structure of isoform A of Escherichia coli GAD (GADA) in complex with glutarate (as glutamate analogue) and pyridoxal 5'-phosphate, PDB ID 1XEY | Escherichia coli |
physiological function | in the GABA synthesis pathway GAD produces GABA from L-glutamate by promoting irreversible alpha-decarboxylation reaction as the most important and rate-limiting step | Escherichia coli |